1. In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa.
- Author
-
Chan, Wei Yee, Hickey, Elizabeth E., Khazandi, Manouchehr, Page, Stephen W., Trott, Darren J., and Hill, Peter B.
- Subjects
MONENSIN ,OTITIS externa ,ETHYLENEDIAMINETETRAACETIC acid ,BACTERIAL cell walls ,PSEUDOMONAS aeruginosa infections ,HUMAN-animal relationships ,MULTIDRUG resistance in bacteria ,CONDUCTIVE hearing loss - Abstract
(a-c) Minimal inhibitory concentration (MIC), fractional inhibitory concentration index (FICI) and dose reduction index (DRI) of the combination effect of (a) narasin and N-acetylcysteine (NAC), (b) narasin and Tris-EDTA and (c) narasin and disodium EDTA (a-c) Minimal inhibitory concentration (MIC), fractional inhibitory concentration index (FICI) and dose reduction index (DRI) of the combination effect of (a) monensin and N-acetylcysteine (NAC), (b) monensin and Tris-EDTA and (c) monensin and disodium EDTA for various bacterial isolates (a-c) Minimal inhibitory concentration (MIC), fractional inhibitory concentration index (FICI) and dose reduction index (DRI) of the combination effect of (a) monensin and N-acetylcysteine (NAC), (b) monensin and Tris-EDTA and (c) monensin and disodium EDTA for various bacterial isolates (a-c) Minimal inhibitory concentration (MIC), fractional inhibitory concentration index (FICI) and dose reduction index (DRI) of the combination effect of (a) monensin and N-acetylcysteine (NAC), (b) monensin and Tris-EDTA and (c) monensin and disodium EDTA for various bacterial isolates. [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF